Impact of Low-Dose Hydrocortisone on the Incidence of Atrial Fibrillation in Patients With Septic Shock: A Propensity Score-Inverse Probability of Treatment Weighting Cohort Study

Abstract

Purpose:

Atrial fibrillation (AF) is common in the intensive care unit (ICU), notably in patients with septic shock for whom inflammation is an already identified risk factor. The aim of this study was to evaluate the effect of low-dose hydrocortisone on AF occurrence in patients with septic shock.

Methods:

We performed a prospective nonrandomized observational study in 5 academic ICUs in France. From November 2012 to June 2014, all patients ≥16 years having septic shock were included, except those who had a history of AF, had a pacemaker, and/or experienced AF during hospitalization before the onset of shock or in whom the onset of shock occurred prior to admission to the ICU. Hydrocortisone was administered at the discretion of the attending physician. The incidence of AF was compared among patients who received hydrocortisone, and the effect of low-dose hydrocortisone on AF was estimated using the inverse probability treatment weighting method based on propensity scores.

Results:

A total of 261 patients were included (no-hydrocortisone group, n = 138; hydrocortisone group, n = 123). Atrial fibrillation occurred in 57 (22%) patients. Atrial fibrillation rates were 33 (24%) and 24 (19%) in no-hydrocortisone patients and hydrocortisone patients, respectively. In the weighted sample, the proportion of patients who developed AF was 28.8% in the no-hydrocortisone group and 16.8% in the hydrocortisone group (difference: −11.9%; 95% confidence interval: −23.4% to −0.5%; P = .040).

Conclusion:

In patients with septic shock, low-dose hydrocortisone was associated with a lower risk of developing AF during the acute phase.

Keywords

atrial fibrillation critical care sepsis shock

Get full access to this article

View all access options for this article.

References

Knotzer

Mayr

Ulmer

. Tachyarrhythmias in a surgical intensive care unit: a case-controlled epidemiologic study. Intensive Care Med. 2000;26(7):908–914.

Seguin

Signouret

Laviolle

Branger

Mallédant

. Incidence and risk factors of atrial fibrillation in a surgical intensive care unit. Crit Care Med. 2004;32(3):722–726.

Annane

Sébille

Duboc

. Incidence and prognosis of sustained arrhythmias in critically ill patients. Am J Respir Crit Care Med. 2008;178(1):20–25.

Brathwaite

Weissman

. The new onset of atrial arrhythmias following major noncardiothoracic surgery is associated with increased mortality. Chest. 1998;114(2):462–468.

Meierhenrich

Steinhilber

Eggermann

. Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: a prospective observational study. Crit Care. 2010;14(3):R108.

Guenancia

Binquet

Laurent

. Incidence and predictors of new-onset atrial fibrillation in septic shock patients in a medical ICU: data from 7-day Holter ECG monitoring. PLoS One. 2015;10(5): e0127168.

Yared

Starr

Torres

. Effects of single dose, postinduction dexamethasone on recovery after cardiac surgery. Ann Thorac Surg. 2000;69(5):1420–1424.

Halonen

Järvinen

. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. JAMA. 2007;297(14):1562–1567.

Keh

Boehnke

Weber-Cartens

. Immunologic and hemodynamic effects of low-dose hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med. 2003;167(4):512–520.

10.

Oppert

Schindler

Husung

. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med. 2005;33(11):2457–2464.

11.

Gialdini

Nearing

Bhave

. Perioperative atrial fibrillation and the long-term risk of ischemic stroke. JAMA. 2014;312(6):616–622.

12.

Shaver

Chen

Janz

. Atrial fibrillation is an independent predictor of mortality in critically ill patients. Crit Care Med. 2015;43(10):2104–2111.

13.

Walkey

Hammill

Curtis

Benjamin

. Long-term outcomes following development of new-onset atrial fibrillation during sepsis. Chest. 2014;146(5):1187–1195.

14.

Annane

Sébille

Charpentier

. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288(7):862–871.

15.

Dellinger

Levy

Carlet

; International Surviving Sepsis Campaign Guidelines Committee, American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36(1): 296–327.

16.

Levy

Fink

Marshall

. SCCM, ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250–1256.

17.

Le Gall

Lemeshow

Saulnier

. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270(24):2957–2963.

18.

Vincent

de Mendonça

Cantraine

. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med. 1998;26(11):1793–1800.

19.

Rosenbaum

Rubin

. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1): 41–55

20.

Brookhart

Schneeweiss

Rothman

Glynn

Avorn

Stürmer

. Variable selection for propensity score models. Am J Epidemiol. 2006;163(12):1149–1156.

21.

Rosenbaum

. Model-based direct adjustment. J Am Stat Assoc. 1987;82(398):387–394.

22.

Austin

. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399–324.

23.

Imbens

. Nonparametric estimation of average treatment effects under exogeneity: a review. Rev Econ Stat. 2004;86(1): 4–29.

24.

Chen

Lin

Chen

. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015;12(4):230–243.

25.

Raiten

Ghadimi

Augoustides

JGT

. Atrial fibrillation after cardiac surgery: clinical update on mechanisms and prophylactic strategies. J Cardiothorac Vasc Anesth. 2015;29(3):806–816.

26.

Whitlock

Chan

Devereaux

. Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials. Eur Heart J. 2008;29(21):2592–2600.

27.

Cappabianca

Rotunno

de Luca Tupputi Schinosa

Ranieri

Paparella

. Protective effects of steroids in cardiac surgery: a meta-analysis of randomized double-blind trials. J Cardiothorac Vasc Anesth. 2011;25(1):156–165.

28.

Dieleman

Nierich

Rosseel

. Dexamethasone for Cardiac Surgery (DECS) Study Group. Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA. 2012;308(17):1761–1767.

29.

Angus

van der Poll

. Severe sepsis and septic shock. N Engl J Med. 2013;369(9):840–851.

30.

Kaufmann

Briegel

Schliephake

. Stress doses of hydrocortisone in septic shock: beneficial effects on opsonization-dependent neutrophil functions. Intensive Care Med. 2008;34(2):344–349.

31.

Ambrus

Benjamin

Bajwa

Hibbert

Walkey

. Risk factors and outcomes associated with new-onset atrial fibrillation during acute respiratory distress syndrome. J Crit Care. 2015;30(5):994–997.

32.

Annane

Bellissant

Bollaert

Briegel

Keh

Kupfer

. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ. 2004;329(7464):480.

33.

Lévesque

Hanley

Kezouh

Suissa

. Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ. 2010;340: b5087.

34.

Kuipers

Klein Klouwenberg

Cremer

. Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review. Crit Care. 2014;18(6):688.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.16 MB